Clinical Trials Directory

Trials / Unknown

UnknownNCT01392781

Markers and Calculation of Cardiovascular Risk in the Distinct Phenotypes of Polycystic Ovary Syndrome

Status
Unknown
Phase
Study type
Observational
Enrollment
300 (estimated)
Sponsor
Aristotle University Of Thessaloniki · Academic / Other
Sex
Female
Age
15 Years – 35 Years
Healthy volunteers
Accepted

Summary

Polycystic ovary syndrome (PCOS) is the most common endocrine disorder and cause of anovulatory infertility among reproductive aged women. According to the revised criteria of 2003, four distinct phenotypes of PCOS can be diagnosed. However, there are emerging evidence supporting the existence of different levels of cardiometabolic risk between the four phenotypic groups of the syndrome. The purpose of this study is to determine the cardiovascular risk of i) normoweight and ii)overweight plus obese women of every one of the four phenotypes of the syndrome as well as the levels of low inflammation serum markers and the possible correlations of the between the outcomes.

Conditions

Timeline

Start date
2011-04-01
Primary completion
2011-10-01
Completion
2012-01-01
First posted
2011-07-13
Last updated
2011-07-13

Locations

1 site across 1 country: Greece

Source: ClinicalTrials.gov record NCT01392781. Inclusion in this directory is not an endorsement.